Sarcoidosis clinical trials

Explore recruiting sarcoidosis clinical trials.

Recruiting sarcoidosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sarcoidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of a 12-week administration of OATD-01, an oral inhibitor of chitinase-1 (CHIT1), for the treatment of active pulmonary sarcoidosis (the KITE study)

Denmark, Germany, Greece, Poland, Norway, France

Therapeutic exploratory (Phase II) EU CTIS Study details

QUIDOSE. Randomized controlled trial testing the efficacy of hydroxychloroquine combined with low dose corticosteroid therapy in pulmonary sarcoidosis.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

SIRIUS Sarcoidosis with moderate to severe facial skin involvement: an open multicenter study of the efficacy and safety of oral sirolimus

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of a 12-week administration of OATD-01, an oral inhibitor of chitinase-1 (CHIT1), for the treatment of active pulmonary sarcoidosis (the KITE study)

Germany, France, Greece, Denmark, Norway, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

HydroxyChloroquine as steroid-sparing Agent in Extra-pulmonary SARcoidosis. A multicenter, prospective, placebo-controlled, randomized trial. CAESAR

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis - A randomized controlled trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Sarcoidosis trials by city

Sarcoidosis in Toronto Sarcoidosis in Vancouver Sarcoidosis in Montreal Sarcoidosis in Calgary Sarcoidosis in Edmonton Sarcoidosis in Ottawa Sarcoidosis in Winnipeg Sarcoidosis in Quebec City Sarcoidosis in Hamilton Sarcoidosis in Kitchener Sarcoidosis in London Sarcoidosis in Halifax Sarcoidosis in New York Sarcoidosis in Los Angeles Sarcoidosis in Chicago Sarcoidosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease